| 摘要 |
Disclosed herein are monoclonal antibodies for an improved detection of HPV-associated pre-malignant lesions, malignant lesions and invasive cancer. Furthermore, methods and uses of the monoclonal antibodies for the detection, diagnosis and/or prognosis HPV-associated pre-malignant lesions, malignant lesions and invasive cancer are disclosed. |
